| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Dec―23 |
Sialoglycan binding triggers spike opening in a human coronavirus, and a high-resolution crystal structure of anti-FLAG M2 in complex with a FLAG peptide |
Matti Pronker |
| 2 |
[GO] |
2024―Dec―23 |
Crystallographic structure of whole nsp14 from SARS-CoV-2 stabilised by a nanobody |
Pierre Gauffre, Anaïs Gaubert, Bruno Canard, François Ferron |
| 3 |
[GO] |
2024―Dec―23 |
Acriflavine as an inhibitor of PlPro SARS-CoV-2: repurposing an old drug for a novel challenge |
Valeria Napolitano, K. Hadian, K. Pyrc, G. M. Popowicz |
| 4 |
[GO] |
2024―May―10 |
Biocrystallography as a means of communication with the general public on the coronavirus and the RNA world |
L. Coudray, A. Gaudry, C. Sauter |
| 5 |
[GO] |
2024―May―10 |
Structural insights into ribonucleoprotein dissociation by nucleocapsid protein interacting with non-structural protein 3 in SARS-CoV-2 |
Xincheng Ni, Yinze Han, Renjie Zhou, Yanmei Zhou, Jian Lei |
| 6 |
[GO] |
2024―May―10 |
Structure-based study of neutralizing antibodies against SARS-CoV-2 |
Hua Xu, Bo Wang, Xiaodong Su |
| 7 |
[GO] |
2024―May―10 |
Discovery of inhibitors targeting viral proteases from SARS-CoV-2 |
Haitao Yang |
| 8 |
[GO] |
2024―May―10 |
Structural basis of immune recognition of SARS-CoV-2 and variants: implications for pancoronavirus vaccines and therapeutics |
Ian A. Wilson |
| 9 |
[GO] |
2024―May―10 |
Characterisation of NiRAN domain of RNA-dependent RNA polymerase of SARS-CoV-2 as a potential drug target and a novel kinase |
Deepsikha Kar, Abhisek Dwivedi, Sayan Chakraborty, Bichitra K. Biswal |
| 10 |
[GO] |
2024―May―10 |
Structural landscape of SARS-CoV-2 entry and activation of spike glycoprotein by engaging unique host factors and potential interventions |
N. Vankadari, M. Sasikala, X. Fang, L. Tian, S. S. Latha, K. Wang, et al. (+4) P. Peng, J. A. Wilce, D. N. Reddy, D. Ghosal |
| 11 |
[GO] |
2024―May―10 |
Cellular activation pathway of bemnifosbuvir (AT-527), a drug candidate against SARS-CoV-2 infections |
A. Chazot, C. Zimberger, M. Feracci, S. Hernandez, C. Falcou, A. Moussa, et al. (+5) S. Good, J.-P. Sommadossi, F. Ferron, K. Alvarez, B. Canard |
| 12 |
[GO] |
2024―May―10 |
Crystal structure of SARS-CoV-2 main protease in complex with nirmatrelvir |
Yinkai Duan |
| 13 |
[GO] |
2024―May―10 |
Structural analysis of SARS-CoV-2 membrane protein |
Z. Zhang |
| 14 |
[GO] |
2024―May―10 |
Structural insight into the mechanism of inhibitor Y180 against SARS-CoV-2 omicron main protease |
R. Zeng, B. X. Quan, J. X. Qiao, K. Wang, J. Lei, S. Y. Yang |
| 15 |
[GO] |
2024―May―10 |
Structural reports of four flavonoids and ITC binding study of one with SARS-CoV-2 papain-like protease |
Hemant P. Yennawar, Anna J. Sigmon, Neela H. Yennawar |
| 16 |
[GO] |
2024―May―10 |
Inhibiting SARS-CoV-2 PLpro |
Dale Calleja, David Komander |
| 17 |
[GO] |
2024―May―10 |
Room-temperature structural studies of SARS-CoV-2 protein, NendoU, with an X-ray free-electron laser |
S. Botha, R. Jernigan, D. Logeswaran, D. Doppler, N. Nagaratnam, M. Sonker, et al. (+23) J.-H. Yang, J. M. Martin-Garcia, M. L. Shelby, T. D. Grant, V. Mariani, A. Tolstikova, M. Z. Sheikh, M. C. Yung, M. A. Coleman, S. Zaare, E. K. Kaschner, M. T. Rabbani, R. Nazari, M. A. Zacks, B. Hayes, R. G. Sierra, M. S. Hunter, S. Lisova, A. Batyuk, C. Kupitz, S. Boutet, D. T. Hansen, R. A. Kirian |
| 18 |
[GO] |
2024―May―10 |
Structural studies of SARS-CoV-2 proteins and their complexes |
Andrzej Joachimiak, Jerzy Osipiuk, Mateusz Wilamowski, Natalia Maltseva, Christine Tesar, Changsoo Chang, et al. (+5) Michael Endres, Lucy Stols, Kemin Tan, Karolina Michalska, Youngchang Kim |
| 19 |
[GO] |
2024―May―10 |
A story of SARS-CoV-2 RNA capping |
Zihe Rao |
| 20 |
[GO] |
2024―May―10 |
Structural basis of biased T cell recognition of immune-dominant epitope of SARS-CoV-2 spike protein |
Priyanka Chaurasia, Thi H. O. Nguyen, Louise C. Rowntree, Jennifer A. Juno, Adam K. Wheatley, Stephen J. Kent, et al. (+3) Katherine Kedzierska, Jamie Rossjohn, Jan Petersen |
| 21 |
[GO] |
2024―May―10 |
Structural bases for the higher adherence to ACE2 conferred by the SARS-CoV-2 spike Q498Y substitution |
E. Erausquin, J. López-Sagaseta |
| 22 |
[GO] |
2024―May―10 |
Structural basis of T cell recognition of SARS-CoV-2 variants |
Stephanie Gras |
| 23 |
[GO] |
2024―May―10 |
Science during a pandemic - remote access to neutron diffractometers |
M. Kirkham, R. Benson, R. Crompton, M. Everett, L. Grace, P. Parker, et al. (+5) H. Skorpenske, J. Thomson, K. Vodopivec, J. Werner, A. White |
| 24 |
[GO] |
2023―Sep―26 |
Structural studies of non-structural protein 15 (Nsp15) endoribonuclease from original SARS-Cov-2 and its variant epsilon for therapeutic intervention |
Manashi Sonowal, Nirupa Nagaratnam, Dhenugen Logeswaran, Rebecca Jernigen, Raimund Fromme, Petra Fromme |
| 25 |
[GO] |
2023―Sep―26 |
Understanding preferences for double-stranded RNA cleavage by SARS-Cov-2 enzyme Nsp15 |
Zoe M. Wright, Kevin John U. Butay, Isha M. Wilson, Geoff A. Mueller, Mario J. Borgnia, Robin E. Stanley |
| 26 |
[GO] |
2023―Sep―26 |
Structural insights into N-linked glycan remodeling of the SARS-Cov-2 spike protein |
Suruchi Singh, Yi Liu, Meghan Burke, Benjamin Jennings, Debajit Dey, Balraj Doray, et al. (+2) Stephen Stein, S. Saif Hasan |
| 27 |
[GO] |
2023―Sep―26 |
Atomic-level determinants of SARS-Cov-2 spike trafficking during infection and vaccination |
Debajit Dey, Suruchi Singh, Enya Qing, Yanan He, Yihong Chen, Benjamin Jennings, et al. (+9) Whitaker Cohn, Lokesh Gakhar, Nicholas J. Schnicker, Brian G. Pierce, Julian P. Whitelegge, Balraj Doray, John P. Orban, Tom Gallagher, S. Saif Hasan |
| 28 |
[GO] |
2023―Mar―17 |
The coronavirus structural taskforce |
G. Santoni, A. Thorn |
| 29 |
[GO] |
2023―Mar―17 |
Inhibitor screening and structural characterization of virulence factors from SARS-CoV-2 |
S. Chatziefthymiou, M. Kuzikov, S. Afandi, E. Crosas, G. Pompidor, H. Taberman, et al. (+4) B. Windschügel, J. Labahn, M. Kolbe, J. Hakanpää |
| 30 |
[GO] |
2023―Mar―17 |
Fighting the enemy - understanding SARS-CoV-2 and its disease-causing mechanisms |
J. Esbjörnsson |
| 31 |
[GO] |
2023―Mar―17 |
Structural characterization of SARS-CoV-2 spike derived peptides presented by the Human Leukocyte Antigen A*29:02 |
L. Murdolo, S. Swaminathan, C. Szeto, C. Smith, S. Gras |
| 32 |
[GO] |
2023―Mar―17 |
Structural bases for the higher adherence to ACE2 conferred by the SARS-CoV-2 spike Q498Y substitution |
E. Erausquin, J. López-Sagaseta |
| 33 |
[GO] |
2022―Sep―15 |
Molecular mechanisms of COVID-19 |
Fang Li |
| 34 |
[GO] |
2022―Sep―15 |
Structure-guided coronavirus vaccine design |
David Veesler |
| 35 |
[GO] |
2022―Sep―15 |
The evolutionary arms race between antibody-mediated immunity and SARS-CoV-2 |
Timothy Bates |
| 36 |
[GO] |
2022―Sep―15 |
Structural insights into 2′-O ribosyl methylation of mRNA cap by SARS-CoV-2 |
Yogesh Gupta |
| 37 |
[GO] |
2022―Sep―15 |
Structure-guided design of biparatopic nanobodies that potently neutralize SARS-CoV-2 and variants |
Javeed Dhobi, Jiansheng Jiang, Lisa F. Boyd, Bernard Lafont, Allison Zeher, Rick Huang, et al. (+3) Di Xia, Kannan Natarajan, David H. Margulies |
| 38 |
[GO] |
2022―Sep―15 |
Creating new inhibitors to SARS-CoV-2 macrodomain using fragments, neutrons and entropy! |
James Fraser |
| 39 |
[GO] |
2022―Sep―15 |
Room-temperature X-ray/neutron crystallography to uncover SARS-CoV-2 main protease function and design potent inhibitors |
Andrey Kovalevsky |
| 40 |
[GO] |
2022―Feb―11 |
PDBe-KB COVID-19 data portal - supporting rapid coronavirus research |
Sameer Velankar |
| 41 |
[GO] |
2022―Feb―11 |
3DBionotes Covid-19 edition |
José Ramon Macias, Ruben Sanchez-Garcia, Pablo Conesa, Erney Ramirez-Aportela, Marta Martinez Gonzalez, Carlos Wert-Carvajal, et al. (+6) Alberto M. Parra-Perez, Joan Segura Mora, Sam Horrell, Andrea Thorn, Carlos O. S. Sorzano, Jose Maria Carazo |
| 42 |
[GO] |
2022―Feb―11 |
The Argentinian Crystal Growing Contest and other educational activities in Argentina during the COVID-19 pandemic |
Sebastián Klinke, Valeria Cintia Fuertes, Vanina Gisela Franco, Clarisa Ester Alvarez, Diego Germán Lamas |
| 43 |
[GO] |
2022―Feb―11 |
Crystallography schools and other educational activities in Latin America during the COVID-19 pandemic |
Diego Germán Lamas |
| 44 |
[GO] |
2022―Feb―11 |
University remote teaching in crystal chemistry during the COVID-19 pandemic: positive and negative aspects |
Olga V. Grineva |
| 45 |
[GO] |
2022―Feb―11 |
Structural basis of mRNA cap modification by SARS-CoV-2: role of metal ions and implications for COVID-19 severity by emerging variants |
Yogesh K. Gupta, Thiruselvam Viswanathan, Anurag Misra, Siu-Hong Chan, Shan Qi, Shailee Arya, et al. (+2) Nan Dai, Luis Martinez-Sobrido |
| 46 |
[GO] |
2022―Feb―11 |
Targeting COVID-19 viral enzymes in an evolving landscape of publishing and peer review |
James Fraser |
| 47 |
[GO] |
2022―Feb―11 |
A structure-guided taxonomicbased approach to the design of broad-spectrum coronavirus protease inhibitors |
Andrew D. Mesecar, Sarah E. St John, Emma K. Lendy, Brandon J. Anson, Mackenzie E. Chapman, Arun K. Ghosh |
| 48 |
[GO] |
2022―Feb―11 |
The Coronavirus Structural Task Force |
Andrea Thorn |
| 49 |
[GO] |
2022―Feb―11 |
Validation of cryo-EM structures of SARS-CoV-2 and mapping genomic mutations |
Sony Malhotra, Martyn Winn, Agnel Praveen Joseph |
| 50 |
[GO] |
2022―Feb―11 |
Crystallographic fragment screening of SARS-CoV-2 drug discovery targets |
Daren Fearon, Alice Douangamath, Ailsa Powell, Alex Dias, Anthony Aimon, Jose Brandao-Neto, et al. (+5) Louise Dunnett, Rachael Skyner, Tyler Gorrie-Stone, Warren Thompson, Frank von Delft |
| 51 |
[GO] |
2022―Feb―11 |
Structural studies towards the development of an oral main protease (Mpro) inhibitor to treat SARS-CoV-2 infection |
Joanne Lemieux, Muhammad Bashir Khan, Jimmy Lu, Elena Arutyunova, James Nieman, D. Lorne Tyrrell, Howard S. Young |
| 52 |
[GO] |
2022―Feb―11 |
Fragment-based drug discovery of SARS-CoV-2 main protease |
Weixiao Song, Sen Li, Ah Wing Edith Chan, Alun Coker |
| 53 |
[GO] |
2022―Feb―11 |
A crystallographic snapshot of SARS-CoV-2 main protease maturation process |
Gabriela D. Noske, Aline Minali Nakamura, Victor O. Gawriljuk, Rafaela S. Fernandes, Gustavo M. A. Lima, Higor V. D. Rosa, et al. (+6) Humberto D. Pereira, Ana C. M. Zeri, Andrey F. Z. Nascimento, Marjorie C. L. C. Freire, Glaucius Oliva, Andre S. Godoy |
| 54 |
[GO] |
2022―Feb―11 |
The temperature-dependent conformational ensemble of SARS-CoV-2 main protease (Mpro) |
Ali Ebrahim, Blake T. Riley, Desigan Kumaran, Babak Andi, Martin R. Fuchs, Sean McSweeney, Daniel A. Keedy |
| 55 |
[GO] |
2022―Feb―11 |
Co-crystallization of hepatitis C virus NS3/4A inhibitors and SARS-CoV-2 main protease using high-density acoustic droplet ejection (ADE) |
Babak Andi, Dale F. Kreitler, Desigan Kumaran, Alexei S. Soares, Jantana Keereetaweep, Jean Jakoncic, et al. (+4) Wuxian Shi, Martin R. Fuchs, John Shanklin, Sean McSweeney |
| 56 |
[GO] |
2022―Feb―11 |
Structure of SARS-CoV-2 papain-like protease PLpro reveals a framework for antiviral inhibitor design |
Vasundara Srinivasan, Nadine Werner, Sven Falke, Hévilla Brognaro, Sebastian Günther, Patrick Y. A. Reinke, et al. (+3) Iqbal Choudhary, Alke Meents, Christian Betzel |
| 57 |
[GO] |
2022―Feb―11 |
Transient complexes of the Nsp7, Nsp8 and Nsp12 in SARS-CoV-2 replication transcription complex |
Greg Hura |
| 58 |
[GO] |
2022―Feb―11 |
Investigation of furin inhibition to block SARS-CoV-2 spike protein cleavage and structural stability via molecular docking and molecular dynamics simulations |
Jaganathan Ramakrishnan, Archana Chinnamadhu, Kumaradhas Poomani |
| 59 |
[GO] |
2022―Feb―11 |
Enhanced peer review - rebuilding early SARS-CoV-2 structures in ISOLDE |
Tristan Ian Croll |
| 60 |
[GO] |
2022―Feb―11 |
Structural basis of SARS-CoV-2 translational shutdown and programmed ribosomal frameshifting |
Nenad Ban |
| 61 |
[GO] |
2022―Feb―11 |
Neutron crystallography for drug design targeting SARS-CoV-2 viral proteins |
Andrey Kovalevsky, Daniel Kneller, Leighton Coates |
| 62 |
[GO] |
2022―Feb―11 |
Integrating a discovery-based remote/hybrid crystallography laboratory module into an undergraduate teaching laboratory during the pandemic |
Joe Tanski |
| 63 |
[GO] |
2022―Feb―11 |
The role of structural biology in pandemic's puzzles: amino acids and short peptides as key players |
Joanna Bojarska, Vasso Apostolopous, John Matsoukas, Jack Feehan, Harry Ridgway, Piotr Zielenkiewicz, Wojciech M. Wolf |
| 64 |
[GO] |
2022―Feb―11 |
Learning in 3D with Pymol and Proteopedia during a pandemic: enzyme catalysis and conformational change |
Roderico Acevedo, Karsten W. Theis |
| 65 |
[GO] |
2021―Oct―21 |
A blended learning approach for a crystallography-based undergraduate practical (under COVID-19 restrictions) |
Peter Horton, Simon Coles |
| 66 |
[GO] |
2021―Oct―21 |
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity |
Michael Joyce |
| 67 |
[GO] |
2021―Oct―21 |
Bioinformatics and 3D structural analysis of the coronavirus main protease active site |
Amy Wu Wu, Mickayla Bacorn, Mary-Agnes Balogun, Cassandra Olivas, Christine Zardecki, Sagar Khare, et al. (+2) Stephen Burley, Joseph Lubin |
| 68 |
[GO] |
2021―Oct―21 |
Biochemical analysis and review of the active site evolution of SARS-CoV-2 and other coronaviruses |
Mickayla Bacorn |
| 69 |
[GO] |
2021―Oct―21 |
A global consortium, next-generation SARS-CoV-2 antibody therapeutics and stabilized spike |
Erica Saphire |
| 70 |
[GO] |
2021―Oct―21 |
Direct visualization of SARS-CoV-2 main protease electrostatics using neutron crystallography |
Daniel Kneller, Stephanie Galanie, Gwyndalyn Phillips, Leighton Coates, Andrey Kovalevsky |
| 71 |
[GO] |
2021―Oct―21 |
Mg2+ and Mn2+ coordinate Cap-0-RNA to position substrates for efficient 2′-O-methyl transfer by SARS-CoV-2 nsp16 |
Monica R. Lemus, George Minasov, Ludmilla Shuvalova, Nicole L. Inniss, Joseph S. Brunzelle, Courtney M. Daczkowski, et al. (+3) Paul Hoover, Andrew D. Mesecar, Karla J. F. Satchell |
| 72 |
[GO] |
2021―Oct―21 |
Understanding the active site of the SARS-CoV-2 papain-like protease (PLPro) |
Mary-Agnes Balogun, Amy Wu Wu, Mickayla Bacorn, Cassandra Olivas, Christine Zardecki, Joseph Lubin, et al. (+2) Sagar Khare, Stephen Burley |
| 73 |
[GO] |
2021―Oct―21 |
Deploying high-throughput protein crystallography-based drug discovery platforms to establish a structure-based drug discovery system for SARS-CoV-2 proteins |
Debanu Das |
| 74 |
[GO] |
2021―Oct―21 |
Structures of synthetic nanobodies in complex with SARS-CoV-2 spike or receptor-binding domain provide insights for developing therapeutics and vaccines |
Jiansheng Jiang, Javeed A. Dhobi, Kannan Natarajan, Lisa F. Boyd, Rick Huang, Allison Zeher, David H. Margulies |
| 75 |
[GO] |
2021―May―11 |
Mapping COVID-19 mutations in 3D: how SARS-CoV-2 has evolved during the first 6 months of the global pandemic |
Aaliyah Khan, Christine Zardecki, Stephen Burley, Sagar Khare |
| 76 |
[GO] |
2021―May―11 |
Delving into COVID-19 'seams': examining the structural fabric of SARS-CoV-2 |
Luz Alfaro, Christine Zardecki, Sagar Khare, Stephen Burley |
| 77 |
[GO] |
2021―May―11 |
Structural insights into the feline coronavirus drug GC376, which inhibits the main protease of SARS-CoV-2 and blocks virus replication |
Joanne Lemieux, Wayne Vuong, Muhammad Bashir Khan, Conrad Fischer, Elena Arutyunova, Tess Lamer, et al. (+8) Justin Shields, Holly A. Saffran, Ryan T. McKay, Marco J. van Belkum, Michael Joyce, Howard S. Young, D. Lorne Tyrrell, John C. Vederas |
| 78 |
[GO] |
2021―May―11 |
Structural analysis of severe acute respiratory syndrome coronavirus-2 proteins: exploring mutations in Nsp13 |
Brea Tinsley, Stephen Burley, Christine Zardecki, Sagar Khare |
| 79 |
[GO] |
2021―May―11 |
Protein Data Bank in the time of coronavirus: how open-access 3D structures are enabling research and development in fundamental biology, biomedicine, biotechnology and drug discovery as we confront the global SARS-CoV-2 pandemic |
Stephen Burley |
| 80 |
[GO] |
2021―May―11 |
Structural basis of recognition of SARS-CoV-2 by neutralizing antibodies isolated from convalescent patients |
Ian Wilson, Meng Yuan, Nicholas C. Wu, Hejun Liu, Chang-Chun D. Lee, Xueyong Zhu |
| 81 |
[GO] |
2021―May―11 |
Crowdsourcing inhibitor discovery against the SARS-CoV-2 main protease |
Nir London |
| 82 |
[GO] |
2021―May―11 |
Understanding the evolution of SARS-CoV-2 non-structural protein 15 (Nsp15) in three dimensions (3D) |
Sophia Staggers, Christine Zardecki, Sagar Khare, Stephen Burley |
| 83 |
[GO] |
2021―May―11 |
Crystallography of SARS-CoV-2 non-structural proteins |
Andrzej Joachimiak, Changsoo Chang, Michael Endres, Robert Jedrzejczak, Youngchang Kim, Natalia Maltseva, et al. (+6) Karolina Michalska, Jerzy Osipiuk, Lucy Stols, Kemin Tan, Christine Tesar, Mateusz Wilamowski |
| 84 |
[GO] |
2021―May―11 |
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes |
Jason McLellan |
